{"id":"NCT01474590","sponsor":"Galderma R&D","briefTitle":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","officialTitle":"Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Associated With 200 mg Doxycycline Capsules Versus Vehicle Gel Associated With Isotretinoin Capsules in the Treatment of Severe Acne","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2013-07","completion":"2013-08","firstPosted":"2011-11-18","resultsPosted":"2017-08-28","lastUpdate":"2021-02-18"},"enrollment":266,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Acne"],"interventions":[{"type":"DRUG","name":"Epiduo/Tactuo","otherNames":[]},{"type":"OTHER","name":"vehicle gel","otherNames":[]},{"type":"DRUG","name":"doxycycline 200mg","otherNames":[]},{"type":"DRUG","name":"Isotretinoin","otherNames":[]}],"arms":[{"label":"Epiduo/Tactuo + doxycycline 200mg","type":"EXPERIMENTAL"},{"label":"Isotretinoin + vehicle gel","type":"ACTIVE_COMPARATOR"}],"summary":"Non-inferiority, randomized, controlled, multi-center, investigator-blind, parallel-group comparison study in subjects with severe acne vulgaris on the face.","primaryOutcome":{"measure":"The Primary Outcome is Overall Success, a Composite Endpoint Including Efficacy and Safety Measurements","timeFrame":"20 weeks","effectByArm":[{"arm":"Epiduo/Tactuo + Doxycycline 200mg","deltaMin":85,"sd":null},{"arm":"Isotretinoin + Vehicle Gel","deltaMin":73,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["Canada"]},"refs":{"pmids":["24934963"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":133},"commonTop":["lip dry","dry skin","cheilitis","naospharyngitis","headache"]}}